Literature DB >> 11458699

The regulation of sympathetic outflow in heart failure. The roles of angiotensin II, nitric oxide, and exercise training.

I H Zucker1, W Wang, R U Pliquett, J L Liu, K P Patel.   

Abstract

Sympatho-excitation is a hallmark of the chronic heart failure (CHF) state. It has long been assumed that this sympatho-excitation is mediated by a reduction in sensory input from cardiopulmonary and arterial baroreceptors. However, recent data suggest that these reflexes may only be important in the initiation of the sympatho-excitatory state and may not be necessary for the sustained increase in sympathetic nerve activity (SNA) in CHF. Two humoral factors that can influence SNA are nitric oxide (NO) and angiotensin II (AngII). Animals with CHF exhibit a downregulation in central gene expression for the neuronal isoform of nitric oxide synthase (nNOS). In addition, blockade of AngII receptors in combination with NO donation reduces SNA in animals with CHF, while NO donation alone has no effect on SNA. Chronic exercise training (EX) reduces both plasma AngII and SNA in rabbits with CHF while improving baroreflex function. Blockade of AT1 receptors enhances baroreflex function in non-EX CHF rabbits, but has little effect in EX CHF rabbits. These data suggest that the sympatho-excitatory state that is typical of CHF is, in part, due to changes in AngII and NO. Depressed baroreflex function and the elevated SNA can be improved by EX in animals with CHF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458699

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  40 in total

1.  Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.

Authors:  Juan Gao; Irving H Zucker; Lie Gao
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

2.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

3.  Exercise training prevents arterial baroreflex dysfunction in rats treated with central angiotensin II.

Authors:  Yan-Xia Pan; Lie Gao; Wei-Zhong Wang; Hong Zheng; Dongmei Liu; Kaushik P Patel; Irving H Zucker; Wei Wang
Journal:  Hypertension       Date:  2007-01-15       Impact factor: 10.190

4.  Spinophilin regulates central angiotensin II-mediated effect on blood pressure.

Authors:  Andrey C da Costa Goncalves; Marco Antonio Peliky Fontes; Enno Klussmann; Fatimunnisa Qadri; Jürgen Janke; Maik Gollasch; Johanna Schleifenbaum; Dominik Müller; Jens Jordan; Jens Tank; Friedrich C Luft; Volkmar Gross
Journal:  J Mol Med (Berl)       Date:  2011-08-05       Impact factor: 4.599

5.  Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats.

Authors:  Yang Yu; Yiling Cao; Balyssa Bell; Xiaolei Chen; Robert M Weiss; Robert B Felder; Shun-Guang Wei
Journal:  Hypertension       Date:  2019-06-03       Impact factor: 10.190

Review 6.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  Interaction between cardiac sympathetic afferent reflex and chemoreflex is mediated by the NTS AT1 receptors in heart failure.

Authors:  Wei-Zhong Wang; Lie Gao; Han-Jun Wang; Irving H Zucker; Wei Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

8.  Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling.

Authors:  Liang Xiao; Karla K V Haack; Irving H Zucker
Journal:  Am J Physiol Cell Physiol       Date:  2013-03-27       Impact factor: 4.249

Review 9.  Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure.

Authors:  George Karayannis; George Kitsios; Haralambos Kotidis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2007-04-21       Impact factor: 4.214

10.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.